Clinical Trial Update: A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) [Phase 4]

View source ↗

Summary

Phase 4 open-label cross-over trial in children/adolescents with primary nocturnal enuresis evaluated two daily doses of Minirin oral lyophilisate over 6 weeks;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Enuresis

Drugs mentioned

• Minirin (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Primary Nocturnal Enuresis | Phase 4 | Status: COMPLETED